LXRX - Lexicon Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Delayed price. Currency in USD
10.74
-0.28 (-2.54%)
At close: 4:00PM EST

10.74 0.00 (0.00%)
After hours: 4:36PM EST

Stock chart is not supported by your current browser
Previous close11.02
Open11.04
Bid10.75 x 300
Ask13.09 x 200
Day's range10.72 - 11.29
52-week range8.07 - 18.00
Volume740,698
Avg. volume741,153
Market cap1.134B
Beta-0.06
PE ratio (TTM)N/A
EPS (TTM)-1.27
Earnings date1 Mar 2018 - 5 Mar 2018
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est24.00
Trade prices are not sourced from all markets
  • 3 Fastest-Growing Diabetes Stocks of 2018 -- According to Wall Street
    Motley Fool2 days ago

    3 Fastest-Growing Diabetes Stocks of 2018 -- According to Wall Street

    Analysts think these three diabetes stocks could soar more than 50% this year. But are they right?

  • Globe Newswire22 days ago

    Lexicon Pharmaceuticals to Present at Upcoming Investor Conference

    A live audio webcast for this conference will be available in the “Investors” section of the Lexicon website at www.lexpharma.com/. Lexicon is a fully integrated biopharmaceutical company that is applying a unique approach to gene science based on Nobel Prize-winning technology to discover and develop precise medicines for patients with serious, chronic conditions. Through the precise targeting of these proteins, Lexicon is pioneering the discovery and development of innovative medicines to safely and effectively treat disease.

  • Lexicon (LXRX) Looks Good: Stock Adds 7.6% in Session
    Zacks2 months ago

    Lexicon (LXRX) Looks Good: Stock Adds 7.6% in Session

    Lexicon (LXRX) was a big mover last session, as the company saw its shares rise more than 7% on the day amid huge volumes.

  • Associated Press3 months ago

    Lexicon reports 3Q loss

    On a per-share basis, the The Woodlands, Texas-based company said it had a loss of 29 cents. The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment ...

By using Yahoo you agree that Yahoo and partners may use Cookies for personalisation and other purposes